A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC

Name: A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC
Published: 2026
License: Public Domain

TaiRx, Inc. · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

oncology

hcc - hepatocellular carcinoma, oncology, hepatocellular carcinoma (hcc), hepatoma, tace, sintilimab, cvm-1118, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC

Related documents